Skip to main navigation Skip to search Skip to main content

Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration

  • IMI DIRECT Consortium
  • Research Centre for Optimal Health, London, United Kingdom
  • Perspectum Diagnostics Ltd., Oxford, United Kingdom
  • Institute of Health Informatics, London, United Kingdom
  • Department of Clinical Sciences, Malmö, Sweden
  • Oxford Centre for Clinical Magnetic Resonance Research, Oxford, United Kingdom
  • Department of Mathematical Sciences, Bath, United Kingdom
  • Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany
  • Boehringer Ingelheim Pharma GmbH & Co. KG, 55216 Ingelheim am Rhein, Germany
  • Clinical Pharmacy, 66123 Saarbrücken, Germany
  • Centre Hospitalier Régional Universitaire de Lille 2, 59037 Lille Cedex, France
  • Institute of Neuroscience, 35127 Padova, Italy
  • Centre National de la Recherche Scientific CNRS, 59046 Lille Cedex, France
  • Imperial College London, W12 0NN London, United Kingdom
  • Center for Biological Sequence Analysis, Denmark
  • Novo Nordisk Foundation Center for Protein Research, DK-2200 Copenhagen, Denmark
  • Wellcome Trust Centre for Human Genetics, OX3 7BN Oxford, United Kingdom
  • Department of Epidemiology and Biostatistics, 1081 HV Amsterdam, Netherlands
  • University of Oxford
  • Wellcome Trust Centre for Human Genetics
  • Oxford NIHR Biomedical Research Center
  • Institute of Cardiovascular Science, London, United Kingdom
  • University College London
  • Lund University
  • Umeå University
  • Harvard University
  • University of Westminster
  • University of Exeter

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background & Aims: Excess liver iron content is common and is linked to the risk of hepatic and extrahepatic diseases. We aimed to identify genetic variants influencing liver iron content and use genetics to understand its link to other traits and diseases. Methods: First, we performed a genome-wide association study (GWAS) in 8,289 individuals from UK Biobank, whose liver iron level had been quantified by magnetic resonance imaging, before validating our findings in an independent cohort (n = 1,513 from IMI DIRECT). Second, we used Mendelian randomisation to test the causal effects of 25 predominantly metabolic traits on liver iron content. Third, we tested phenome-wide associations between liver iron variants and 770 traits and disease outcomes. Results: We identified 3 independent genetic variants (rs1800562 [C282Y] and rs1799945 [H63D] in HFE and rs855791 [V736A] in TMPRSS6) associated with liver iron content that reached the GWAS significance threshold (p <5 × 10−8). The 2 HFE variants account for ∼85% of all cases of hereditary haemochromatosis. Mendelian randomisation analysis provided evidence that higher central obesity plays a causal role in increased liver iron content. Phenome-wide association analysis demonstrated shared aetiopathogenic mechanisms for elevated liver iron, high blood pressure, cirrhosis, malignancies, neuropsychiatric and rheumatological conditions, while also highlighting inverse associations with anaemias, lipidaemias and ischaemic heart disease. Conclusion: Our study provides genetic evidence that mechanisms underlying higher liver iron content are likely systemic rather than organ specific, that higher central obesity is causally associated with higher liver iron, and that liver iron shares common aetiology with multiple metabolic and non-metabolic diseases. Lay summary: Excess liver iron content is common and is associated with liver diseases and metabolic diseases including diabetes, high blood pressure, and heart disease. We identified 3 genetic variants that are linked to an increased risk of developing higher liver iron content. We show that the same genetic variants are linked to higher risk of many diseases, but they may also be associated with some health advantages. Finally, we use genetic variants associated with waist-to-hip ratio as a tool to show that central obesity is causally associated with increased liver iron content.
Original languageEnglish
Pages (from-to)594-602
Number of pages9
JournalJournal of hepatology
Volume71
Issue number3
DOIs
Publication statusPublished - 1 Sept 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration'. Together they form a unique fingerprint.

Cite this